This finding is further supported by flow cytometry detection of 45.72% aberrant CD5−/CD10− mature B-cells, a result that excludes chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and mantle cell lymphoma. The gene discussed is CD5; the disease is mantle cell lymphoma.